Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Paul Turnbull

- PMLiVE

Keep the Beat Going: Education and Impact at the European Society of Cardiology Heart Failure Congress 2026

Did you know? Over 320,000 learners have engaged with heart failure content on Medscape. With such an enthusiastic audience for our education, we’re thrilled to be joining cardiology professionals from...

Medscape Education

- PMLiVE

The Power of Partnership in Respiratory Care

In the fast-paced world of modern medicine, success is often measured by the volume of tests and the precision of data. However, as Dr. Doreen Addrizzo-Harris and Dr. Martina Flammer...

Medscape Education

- PMLiVE

UCB presentation highlights impacts of epilepsy on daily life

The data underlines the consequences of disrupted sleep for patients and caregivers

- PMLiVE

Inventiva appoints Axel-Sven Malkomes as Chief Financial Officer

Malkomes was most recently CFO at CureVac

Person_Swimming

Why clinical innovation doesn’t translate into real-life outcomes

We’ve made extraordinary progress in healthcare. However, outcomes depend on whether people can make treatment work in their lives.

Mednet

- PMLiVE

Strategies to enhance the provider and patient EAP experience

Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.

Uniphar

- PMLiVE

Biogen agrees $850m felzartamab rights deal with TJ Biopharma

The agreement gives Biogen full global rights to the investigational antibody across immune-mediated diseases

- PMLiVE

myTomorrows partners with Rare Disease Research to boost rare disease referrals

The collaboration aims to improve patient identification and access to clinical trials

- PMLiVE

Sanofi’s Tzield gets expanded FDA approval for early-stage type 1 diabetes

The treatment can be used to delay the onset of clinical type 1 diabetes

- PMLiVE

Helus Pharma appoints Ken Kramer as Senior VP, Medical Affairs

Kramer most recently served as VP and Head of Medical Neuroscience at Bristol Myers Squibb

- PMLiVE

Why the field is critical tonext-generation marketing

AI is fundamentally changing the way marketing operates omnichannel journeys, enabling true next-best communication

- PMLiVE

AstraZeneca reports positive phase 3 data for tozorakimab in COPD

COPD affects nearly 400 million people globally and is the third leading cause of death worldwide

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links